Is Nonalcoholic Fatty Liver Disease Not a Risk Factor for Cardiovascular Disease: Not Yet Time for a Change of Heart

Jacqueline B Henson¹, Michael Roden^{2

3

4}, Giovanni Targher⁵, Kathleen E Corey⁶

Affiliations

¹ Department of Medicine, Massachusetts General Hospital, Boston, MA.
² Division of Endocrinology and Diabetology, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.
³ Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
⁴ German Center for Diabetes Research, München-Neuherberg, Germany.
⁵ Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy.
⁶ Liver Center, Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Boston, MA.

Comment

Jacqueline B Henson et al. Hepatology. 2020 May.

. 2020 May;71(5):1867-1869.

doi: 10.1002/hep.31156.

Jacqueline B Henson¹, Michael Roden^{2

3

4}, Giovanni Targher⁵, Kathleen E Corey⁶

¹ Department of Medicine, Massachusetts General Hospital, Boston, MA.
² Division of Endocrinology and Diabetology, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.
³ Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
⁴ German Center for Diabetes Research, München-Neuherberg, Germany.
⁵ Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy.
⁶ Liver Center, Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Boston, MA.

No abstract available

Comment on

Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults.
Alexander M, Loomis AK, van der Lei J, Duarte-Salles T, Prieto-Alhambra D, Ansell D, Pasqua A, Lapi F, Rijnbeek P, Mosseveld M, Avillach P, Egger P, Dhalwani NN, Kendrick S, Celis-Morales C, Waterworth DM, Alazawi W, Sattar N. Alexander M, et al. BMJ. 2019 Oct 8;367:l5367. doi: 10.1136/bmj.l5367. BMJ. 2019. PMID: 31594780 Free PMC article.

1. Adams LA, Anstee QM, Tilg H, Targher G. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases. Gut 2017;66:1138-1153.
1. Alexander M, Loomis AK, van der Lei J, Duarte-Salles T, Prieto-Alhambra D, Ansell D, et al. Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults. BMJ 2019;367:l5367.
1. Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology 2018;67:328-357.
1. European Association for the Study of the Liver, European Association for the Study of Diabetes, European Association for the Study of Obesity. EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol 2016;64:1388-1402.
1. Targher G, Byrne CD, Lonardo A, Zoppini G, Barbui C. Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis. J Hepatol 2016;65:589-600.